Links between metabolism and cancer.
暂无分享,去创建一个
[1] P. Carmeliet,et al. Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (vol 394, pg 485, 1998) , 1998 .
[2] L. Coussens,et al. Immune microenvironments in solid tumors: new targets for therapy. , 2011, Genes & development.
[3] Chi V Dang,et al. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.
[4] Gregory Stephanopoulos,et al. Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.
[5] Gavin Kelly,et al. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. , 2012, Cancer discovery.
[6] David Botstein,et al. Metabolic cycling in single yeast cells from unsynchronized steady-state populations limited on glucose or phosphate , 2010, Proceedings of the National Academy of Sciences.
[7] Yanping Zhang,et al. The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine. , 2011, Genes & cancer.
[8] J. Licht,et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.
[9] Frank M. Sacks,et al. IDH 1 and IDH 2 Mutations in Gliomas , 2009 .
[10] G. Semenza,et al. Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 , 2007, Molecular and Cellular Biology.
[11] Paolo Sassone-Corsi,et al. Connecting Threads: Epigenetics and Metabolism , 2012, Cell.
[12] B. Spiegelman,et al. Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.
[13] T. Finkel,et al. Signal transduction by reactive oxygen species , 2011, The Journal of cell biology.
[14] J. Nevins,et al. Ras enhances Myc protein stability. , 1999, Molecular cell.
[15] Kevin M. Ryan,et al. p53 and metabolism , 2009, Nature Reviews Cancer.
[16] Jason W. Locasale,et al. Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.
[17] A. Levine,et al. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function , 2010, Proceedings of the National Academy of Sciences.
[18] G. Semenza,et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.
[19] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[20] D. Dressman,et al. Heteroplasmic mitochondrial DNA mutations in normal and tumor cells , 2010, Nature.
[21] Kun-Liang Guan,et al. Regulation of intermediary metabolism by protein acetylation. , 2011, Trends in biochemical sciences.
[22] G. Semenza,et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression , 2010, Proceedings of the National Academy of Sciences.
[23] S. Kalhan,et al. The Key Role of Anaplerosis and Cataplerosis for Citric Acid Cycle Function* , 2002, The Journal of Biological Chemistry.
[24] William A Weiss,et al. Principles and Current Strategies for Targeting Autophagy for Cancer Treatment , 2011, Clinical Cancer Research.
[25] D. Kilburn,et al. The energetics of mammalian cell growth. , 1969, Journal of cell science.
[26] O. Warburg. On the origin of cancer cells. , 1956, Science.
[27] H. Stanley,et al. Common scale-invariant patterns of sleep-wake transitions across mammalian species. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] R A Jungmann,et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] Yixue Li,et al. Regulation of Cellular Metabolism by Protein Lysine Acetylation , 2010, Science.
[30] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[31] D. Botstein,et al. Metabolic cycling without cell division cycling in respiring yeast , 2011, Proceedings of the National Academy of Sciences.
[32] J. Pouysségur,et al. Hypoxia and energetic tumour metabolism. , 2011, Current opinion in genetics & development.
[33] E. Gottlieb,et al. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.
[34] John D Gordan,et al. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. , 2007, Cancer cell.
[35] 이연수. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .
[36] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[37] D. Ayer,et al. An extended Myc network contributes to glucose homeostasis in cancer and diabetes. , 2011, Frontiers in bioscience.
[38] C. Thompson,et al. Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.
[39] Paolo Sassone-Corsi,et al. Metabolism and cancer: the circadian clock connection , 2009, Nature Reviews Cancer.
[40] Christian M. Metallo,et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.
[41] W. Marston Linehan,et al. Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.
[42] L. Jacobs,et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] Jason W Locasale,et al. Metabolic flux and the regulation of mammalian cell growth. , 2011, Cell metabolism.
[44] Zhiping Weng,et al. Global mapping of c-Myc binding sites and target gene networks in human B cells , 2006, Proceedings of the National Academy of Sciences.
[45] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[46] Jesse M. Platt,et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.
[47] David M. Sabatini,et al. Tumours with PI3K activation are resistant to dietary restriction , 2009, Nature.
[48] G. Mills,et al. Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and -independent mechanisms , 2011, Nature Medicine.
[49] G. Semenza. HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.
[50] K. Bhat,et al. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. , 2010, Cancer cell.
[51] D. Ayer,et al. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity , 2009, Proceedings of the National Academy of Sciences.
[52] S. Hankinson,et al. Night Work and Risk of Breast Cancer , 2006, Epidemiology.
[53] J. Nagy,et al. Why don't all whales have cancer? A novel hypothesis resolving Peto's paradox. , 2007, Integrative and comparative biology.
[54] Bert Vogelstein,et al. Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.
[55] D. Felsher,et al. MYC as a regulator of ribosome biogenesis and protein synthesis , 2010, Nature Reviews Cancer.
[56] C. Townsend,et al. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. , 2003, Cancer research.
[57] S. Sugano,et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species , 2010, Proceedings of the National Academy of Sciences.
[58] J. Maris,et al. Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. , 2010, Cancer research.
[59] B. Wold,et al. Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. , 1994, Molecular biology of the cell.
[60] James R Broach,et al. Protein kinase A and TORC1 activate genes for ribosomal biogenesis by inactivating repressors encoded by Dot6 and its homolog Tod6 , 2009, Proceedings of the National Academy of Sciences.
[61] Noel Southall,et al. Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. , 2010, Bioorganic & medicinal chemistry letters.
[62] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[63] J. Nevins,et al. A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis , 2009, PLoS genetics.
[64] S. Perkins,et al. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. , 2010, Carcinogenesis.
[65] I. Ben-Sahra,et al. Metformin and cancer therapy , 2012, Current opinion in oncology.
[66] D. Tindall,et al. Dynamic FoxO transcription factors , 2007, Journal of Cell Science.
[67] Brian Keith,et al. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. , 2008, Cancer cell.
[68] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[69] Steven L McKnight,et al. Restriction of DNA Replication to the Reductive Phase of the Metabolic Cycle Protects Genome Integrity , 2007, Science.
[70] Abhishek K. Jha,et al. Full-length human glutaminase in complex with an allosteric inhibitor. , 2011, Biochemistry.
[71] J. Uhm. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .
[72] C. Dang,et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.
[73] Peder E. Z. Larson,et al. 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. , 2011, Cell metabolism.
[74] Tak W. Mak,et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations , 2010, The Journal of experimental medicine.
[75] Chenguang Wang,et al. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect , 2011, Cell cycle.
[76] T. Fan,et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.
[77] Bin Wang,et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.
[78] Eileen White,et al. Autophagy and Metabolism , 2010, Science.
[79] M. V. Vander Heiden. Targeting cancer metabolism: a therapeutic window opens. , 2011, Nature reviews. Drug discovery.
[80] H. Christofk,et al. Identification of small molecule inhibitors of pyruvate kinase M2. , 2010, Biochemical pharmacology.
[81] D. Green,et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.
[82] J. Cleveland,et al. c-myc transactivates the ornithine decarboxylase gene. , 1992, Current topics in microbiology and immunology.
[83] N. Isern,et al. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry , 2009, Oncogene.
[84] A. Levine,et al. The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.
[85] C. Supuran,et al. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors. , 2011, Journal of medicinal chemistry.
[86] Julien Verrax,et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.
[87] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[88] Rameen Beroukhim,et al. Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene. , 2011, Cancer discovery.
[89] M. Dewhirst,et al. Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. , 2005, Cancer research.
[90] Ana Maria Cuervo,et al. Autophagy in the cellular energetic balance. , 2011, Cell metabolism.
[91] C. Maley,et al. Peto's Paradox: evolution's prescription for cancer prevention. , 2011, Trends in ecology & evolution.
[92] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[93] Joseph S. Takahashi,et al. Circadian Integration of Metabolism and Energetics , 2010, Science.
[94] J. Zhuang,et al. p53: exercise capacity and metabolism , 2012, Current opinion in oncology.
[95] D. Rubinsztein,et al. Autophagy and Aging , 2011, Cell.
[96] Hongkai Ji,et al. Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation , 2011, PloS one.
[97] B. Faubert,et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. , 2011, Genes & development.
[98] Davide Ruggero,et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency , 2008, Nature.
[99] A. Dey,et al. Using a functional enzyme model to understand the chemistry behind hydrogen sulfide induced hibernation , 2009, Proceedings of the National Academy of Sciences.
[100] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[101] Brian Keith,et al. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.
[102] Succinate dehydrogenase. , 1973, Advances in enzymology and related areas of molecular biology.
[103] N. Ilić,et al. PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis , 2011, Proceedings of the National Academy of Sciences.
[104] L. Lau,et al. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[105] P. Ray,et al. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. , 2012, Cellular signalling.
[106] Sterling C. Johnson,et al. Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys , 2009, Science.
[107] Takashi Tsukamoto,et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.
[108] H. Coller,et al. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. , 2010, Genes & development.
[109] R. Deberardinis,et al. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.
[110] Patrick H Bradley,et al. Yeast cells can access distinct quiescent states. , 2011, Genes & development.
[111] V. Longo,et al. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. , 2010, Trends in pharmacological sciences.
[112] H. Christofk,et al. Identification of small molecule inhibitors of pyruvate kinase M 2 , 2010 .
[113] J. Marine,et al. Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency , 2012, Oncogene.
[114] James H Brown,et al. Scaling of number, size, and metabolic rate of cells with body size in mammals , 2007, Proceedings of the National Academy of Sciences.
[115] A. Yalçin,et al. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. , 2009, Experimental and molecular pathology.
[116] Kathryn A. O’Donnell,et al. Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.
[117] Kathryn A. O’Donnell,et al. The c-Myc target gene network. , 2006, Seminars in cancer biology.
[118] R. Youle,et al. Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.
[119] J. Dark,et al. Annual lipid cycles in hibernators: integration of physiology and behavior. , 2005, Annual review of nutrition.
[120] A. Schulze,et al. Targeting cancer metabolism--aiming at a tumour's sweet-spot. , 2012, Drug discovery today.
[121] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[122] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[123] O. Delpuech,et al. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression , 2011, Cell Death and Differentiation.
[124] G. Semenza,et al. Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.
[125] P. Robson,et al. Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis , 2012, Cell.
[126] M. Oren,et al. Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. , 2012, Molecular cell.
[127] V. Savage,et al. A Quantitative Theory of Solid Tumor Growth, Metabolic Rate and Vascularization , 2011, PloS one.
[128] M E Greenberg,et al. Myc requires distinct E2F activities to induce S phase and apoptosis. , 2001, Molecular cell.
[129] C. Grandori,et al. Activation by c-Myc of transcription by RNA polymerases I, II and III. , 2006, Biochemical Society symposium.
[130] C. Dang,et al. Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.
[131] Gregory Stephanopoulos,et al. Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell Line* , 2008, Journal of Biological Chemistry.
[132] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[133] K. Kaluarachchi,et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. , 2010, The Journal of clinical investigation.
[134] J. Siegel. Clues to the functions of mammalian sleep , 2005, Nature.
[135] A. Cassago,et al. Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism , 2012, Proceedings of the National Academy of Sciences.
[136] John A. Hall,et al. mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[137] M. Celeste Simon,et al. The impact of O2 availability on human cancer , 2008, Nature Reviews Cancer.
[138] R. Klose,et al. The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases , 2011, EMBO reports.
[139] Oksana Gavrilova,et al. p53 Regulates Mitochondrial Respiration , 2006, Science.
[140] R. Shaw,et al. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.
[141] R. Stevens,et al. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. , 2012, European journal of cancer.